Skip to main content
. 2019 Nov 15;11(11):1021–1030. doi: 10.4251/wjgo.v11.i11.1021

Table 2.

Relative dose intensity of the capecitabine or S-1 for advanced gemcitabine refractory pancreatic cancer

Capecitabine (n = 41) S-1 (n = 40) P value
Duration of treatment, months
Median 1.7 2.0 0.120
Range 0.7-6.9 0.8-6.2
Dose intensity
Median 0.92 1.00 0.986
Range 0.70-1.00 0.50-1.00